US 8323961
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
granted A61KA61K2039/5256A61K2039/53
Quick answer
US patent 8323961 (HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K39/12, A61K39/21